WebSite > Atop Bio-Tech (Tianjin) Co., Ltd. (Atop)

Atop Bio-Tech (Tianjin) Co., Ltd. (Atop)

  • Company Name Atop Bio-Tech (Tianjin) Co., Ltd. (Atop)
  • Tel 022-66200236
  • Email sales@atop-biotech.com
  • WebSite http://www.atop-biotech.com
  • CB Index 60
  •       Atop Bio-Tech (Tianjin) Co., Ltd. (Atop) was established in the national innovation base, the Binhai New Area of Tianjin city. Wuqing district has built in test and commercialization of production base. The company is a comprehensive enterprise of new drug research and development, production and services in organic chemistry and modern medicine chemical technology as the core of the. At present, the drug varieties mainly covers the treatment of respiratory diseases, cardiovascular and cerebrovascular disease, lung cancer, infectious diseases, anti pain medication, part of the product has been put into mass production. Has a large technical and cost advantage at home and abroad. Contract customized pharmaceutical intermediates species mainly covers the pyridine series, boronic acid series, heterocyclic series, benzene series and other types of compounds. Making making company from its inception has been to establish R & D Center for technical support, industry oriented as the company's future development strategy. This can enable the company to keep the core competitiveness of leading through industrialization, large-scale production, to provide customers with more cost competitive products and fast, efficient service. In the future, the company will further expand the new drug R & D service content, ability and level of service, for customers to provide quality, efficient new drug R & D, production and service
Atop Bio-Tech (Tianjin) Co., Ltd. (Atop) Product List
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •